{"pageContent": "Objectives: Our aim was to assess whether magnetic resonance imaging (MRI) features predict recurrence-free survival (RFS) after prostate cancer high-intensity focused ultrasound (HIFU) ablation.", "metaData": {"source": "Local staging of prostate cancer: comparative accuracy of T2-weighted endorectal MR imaging and transrectal ultrasound\nhttps://pubmed.ncbi.nlm.nih.gov/22920360/"}}